Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277M Buy
2,152,022
+372,843
+21% +$43.6M 0.55% 29
2026
Q1
$214M Sell
1,779,179
-86,265
-5% -$9.96M 0.52% 28
2025
Q4
$196M Sell
1,865,444
-40,586
-2% -$3.81M 0.46% 35
2025
Q3
$160M Sell
1,906,030
-178,208
-9% -$14.7M 0.4% 36
2025
Q2
$165M Buy
2,084,238
+245,774
+13% +$19.5M 0.41% 41
2025
Q1
$165M Sell
1,838,464
-47,882
-3% -$4.47M 0.5% 30
2024
Q4
$188M Buy
1,886,346
+72,001
+4% +$7.42M 0.56% 24
2024
Q3
$206M Sell
1,814,345
-130,037
-7% -$15.4M 0.69% 26
2024
Q2
$241M Buy
1,944,382
+20,032
+1% +$2.58M 0.89% 15
2024
Q1
$254M Buy
+1,924,350
New +$237M 0.8% 18

Other funds holding MRK

Danske Bank's MRK Position: Q2 2026 in Review

Danske Bank increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $43.6M and bringing the position to 2,152,022 shares worth $277M. The position accounts for 0.55% of the portfolio, ranked #29.

Danske Bank first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Danske Bank held 2,152,022 shares of Merck worth $277M as of Q2 2026.
  • Danske Bank bought 372,843 Merck shares in Q2 2026, an estimated $43.6M.
  • Merck made up 0.55% of Danske Bank's portfolio in Q2 2026, its #29 holding.
  • Danske Bank first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.